Delve vs Phillips-Medisize: full comparison for 2026
Quick verdict
Delve (4.0/5) edges ahead of Phillips-Medisize (3.9/5) overall. Delve is the better choice for user research and industrial design for medtech. Phillips-Medisize is the stronger option for drug delivery devices needing high-volume production. The right choice depends on your project size, budget, and required tech stack.
Delve vs Phillips-Medisize: head-to-head summary
| Criterion | Delve | Phillips-Medisize |
|---|---|---|
| Founded | 2021 | 1964 |
| HQ | Madison, WI, USA | Hudson, WI, USA |
| Team size | 200–500 | ~7,000 |
| Rating | 4.0 / 5 | 3.9 / 5 |
| Primary differentiator | Design research and industrial design depth from two long-established US studios | Design, molding and assembly of drug delivery devices under one global quality system |
| Pricing model | Time and materials, phased fixed project | Development contract plus manufacturing supply agreement |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | SolidWorks, Usability engineering, Rapid prototyping | Injection molding, Automated assembly, BLE |
| Industries served | Wearables & remote monitoring, Surgical & therapeutic devices, Consumer products, Industrial | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
Delve vs Phillips-Medisize: overview
Delve
Delve is a product design and innovation firm headquartered in Madison, Wisconsin, with studios in Boston, Philadelphia and San Francisco. Trinity Hunt Partners bought it in 2021 and merged it with Philadelphia's Bresslergroup (founded 1970), and the combined business now operates under the Delve name and later acquired digital design firm altr. Its team is estimated at 200 to 500 people. Delve says it designed and engineered the Dexcom G6 continuous glucose monitor (per company website; independently unverifiable), and medical devices are a large share of its work alongside consumer and industrial products.
Phillips-Medisize
Phillips-Medisize is a subsidiary of Molex, itself owned by Koch Industries, and provides outsourced design, development and manufacturing to pharma, diagnostics and medical device companies. It is based in Wisconsin and has about 7,000 employees. Molex's purchase of inhalation specialist Vectura added combination-product expertise, and the combined team includes more than 1,200 engineers and scientists across 30 sites. A $110M manufacturing campus in Katowice, Poland, opened in November 2023.
Services and capabilities: Delve vs Phillips-Medisize
| Capability | Delve | Phillips-Medisize |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✗ | ✗ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✓ | ✗ |
| Mechanical engineering | ✓ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✗ | ✓ |
| Manufacturing & scale-up | ✗ | ✓ |
Tech stack comparison: Delve vs Phillips-Medisize
| Framework / platform | Delve | Phillips-Medisize |
|---|---|---|
| Embedded C/C++ | ✓ | N/A |
| Embedded Linux | N/A | N/A |
| RTOS | N/A | N/A |
| BLE | N/A | ✓ |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | N/A | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | N/A | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Delve vs Phillips-Medisize
| Criterion | Delve | Phillips-Medisize |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Consulting, Fixed project, Time & materials | Fixed project, Manufacturing contract |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Delve vs Phillips-Medisize
| Dimension | Delve | Phillips-Medisize |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Wearables & remote monitoring, Surgical & therapeutic devices, Consumer products | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
| Best use cases | Industrial design and user research for a wearable, Human factors work on a home-use device | Autoinjector or pen injector development and production, Inhaler device for a pharma combination product |
| Typical project type | Consulting | Fixed project |
Delve vs Phillips-Medisize: pros and cons
| Delve | |
|---|---|
| + | Strong user research and industrial design, important for patient-worn devices |
| + | Multiple US studios |
| + | Public wearable CGM experience |
| + | Bresslergroup brings a long patent and design-award record |
| - | Private-equity owned since 2021 and built through mergers |
| - | Medical is a large share, but consumer and industrial work compete for attention |
| - | ISO 13485 certification was not confirmed in our research |
| Phillips-Medisize | |
|---|---|
| + | Very large manufacturing footprint across the US, Europe and Asia |
| + | Vectura deal added deep inhalation and combination-product skills |
| + | Development and manufacturing under one quality system |
| + | Experience with connected drug delivery |
| - | Owned by Molex and Koch Industries, so it suits large pharma more than small startups |
| - | Development work is usually tied to a manufacturing agreement |
| - | Less suited to software-heavy or early research projects |
Who should choose Delve?
A typical fit: industrial design and user research for a wearable.
Design research and industrial design depth from two long-established US studios. Minimum engagement is not publicly disclosed. Works best with clients in Wearables & remote monitoring, Surgical & therapeutic devices, Consumer products, Industrial.
Who should choose Phillips-Medisize?
A typical fit: autoinjector or pen injector development and production.
Design, molding and assembly of drug delivery devices under one global quality system. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices.
Decision matrix: Delve vs Phillips-Medisize
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Delve |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Delve (Not disclosed) vs Phillips-Medisize (Not disclosed) |
| You need specialist depth in a specific vertical | Delve |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Delve vs Phillips-Medisize
| Use case | Delve fit | Phillips-Medisize fit | Winner |
|---|---|---|---|
| Industrial design and user research for a wearable | Strong | Limited | Delve |
| Human factors work on a home-use device | Strong | Limited | Delve |
| Autoinjector or pen injector development and production | Limited | Strong | Phillips-Medisize |
| Inhaler device for a pharma combination product | Limited | Strong | Phillips-Medisize |
Verdict: Delve vs Phillips-Medisize
Delve (4.0/5) is the stronger overall choice for most Medical Device Development projects. Design research and industrial design depth from two long-established US studios.
Phillips-Medisize (3.9/5) is worth a look if you need inhaler device for a pharma combination product. If your situation matches that, Phillips-Medisize is a competitive option.
Related comparisons
Delve vs Phillips-Medisize FAQ
Is Delve better than Phillips-Medisize?
Delve (4.0/5) scores higher overall, but "better" depends on your use case. Delve's strongest advantage: strong user research and industrial design, important for patient-worn devices. Phillips-Medisize's strongest advantage: very large manufacturing footprint across the US, Europe and Asia.
How do Delve and Phillips-Medisize differ in pricing?
Delve uses time and materials, phased fixed project pricing. Phillips-Medisize uses development contract plus manufacturing supply agreement pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Delve or Phillips-Medisize?
Delve is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Delve and Phillips-Medisize?
Delve's primary differentiator is: design research and industrial design depth from two long-established US studios. Phillips-Medisize's primary differentiator is: Design, molding and assembly of drug delivery devices under one global quality system. They also differ in team size (200–500 vs ~7,000), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Wearables & remote monitoring, Surgical & therapeutic devices vs Drug delivery, Diagnostics & lab devices).
Verify all details directly with each company before making a decision.